Timothy Daley
Stock Analyst at Wells Fargo
(2.01)
# 3,061
Out of 5,124 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $44.97 | +3.80% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $6.15 | +225.20% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $96.75 | -1.81% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $47.11 | +52.83% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $136.07 | +6.56% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,394.19 | -6.76% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $379.83 | -24.97% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $228.92 | +7.90% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $199.48 | +37.86% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $250.88 | +7.62% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $6.99 | +300.57% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.12 | +73.96% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $579.45 | -10.26% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.56 | +1,501.14% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $163.86 | +12.90% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.49 | +14.11% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $225.41 | -2.40% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $182.26 | +20.71% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $11.46 | +144.33% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $173.53 | -19.32% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $58.81 | +53.04% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $44.97
Upside: +3.80%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $6.15
Upside: +225.20%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $96.75
Upside: -1.81%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $47.11
Upside: +52.83%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $136.07
Upside: +6.56%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,394.19
Upside: -6.76%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $379.83
Upside: -24.97%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $228.92
Upside: +7.90%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $199.48
Upside: +37.86%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $250.88
Upside: +7.62%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $6.99
Upside: +300.57%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.12
Upside: +73.96%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $579.45
Upside: -10.26%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.56
Upside: +1,501.14%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $163.86
Upside: +12.90%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.49
Upside: +14.11%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $225.41
Upside: -2.40%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $182.26
Upside: +20.71%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $11.46
Upside: +144.33%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $173.53
Upside: -19.32%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $58.81
Upside: +53.04%